People · Operator

Michael H. Slayton

Named in public records as an officer, director or promoter · active 2010–2010 · Other Health Care

1
Companies
1
Filings
$11.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Ulthera IncOther Health CareSeries A$11.7M$213.1M2010
Operator network

Michael H. Slayton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Justin T. Klein · 2 companies · 1 sharedJustin T. KleinMatthew E. Likens · 2 companies · 1 sharedMatthew E. LikensChip F. Linehan · 1 companies · 1 sharedChip F. LinehanChip T. Linehan · 1 companies · 1 sharedChip T. LinehanDavid F. Porter · 1 companies · 1 sharedDavid F. PorterDavid T. Porter · 1 companies · 1 sharedDavid T. PorterJames G. Atkinson · 1 companies · 1 sharedJames G. AtkinsonMichael T. Peterson · 1 companies · 1 sharedMichael T. Peters…Michael T. Slayton, Ph.D. · 1 companies · 1 sharedMichael T. Slayto…Randall E. Miller · 1 companies · 1 sharedRandall E. MillerRandall E. Miller, Ph.D. · 1 companies · 1 sharedRandall E. Miller…Robert F. Byrnes · 1 companies · 1 sharedRobert F. ByrnesRobert T. Byrnes · 1 companies · 1 sharedRobert T. ByrnesUlthera Inc · $11.7M raisedUlthera IncMichael H. SlaytonMS
Michael H. Slayton Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Michael H. Slayton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Justin T. Klein12
Matthew E. Likens12
Randall E. Miller, Ph.D.11
Chip T. Linehan11
David T. Porter11
Michael T. Peterson11
Michael T. Slayton, Ph.D.11
James G. Atkinson11
Robert T. Byrnes11
Chip F. Linehan11
Robert F. Byrnes11
Randall E. Miller11
David F. Porter11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.